Study of Fentanyl-Propofol-EMLA of L.M.X4 Technique for Bone Marrow Aspiration
Information source: St. Jude Children's Research Hospital
Information obtained from ClinicalTrials.gov on June 20, 2008 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Bone Marrow Disease; Pain
Intervention: Fentanyl (Drug); EMLA (Drug); L.M.X4 (Drug); Propofol (Drug)
Phase: Phase 3
Status: Active, not recruiting
Sponsored by: St. Jude Children's Research Hospital Official(s) and/or principal investigator(s): Doralina L. Anghelescu, M.D., Principal Investigator, Affiliation: St. Jude Children's Research Hospital
Summary
St. Jude Children's Research Hospital is studying the best ways to prevent pain during and
after procedures such as bone marrow aspiration and lumbar puncture with intrathecal (in the
spinal fluid) chemotherapy. Researchers will study the effectiveness of combining anesthetics
(medicines that help people sleep) and analgesics (medicines that relieve pain). Researchers
believe that a combination of fentanyl (analgesic) and propofol (anesthetic), along with
applying the skin-numbing-cream EMLA or L. M.X4™ on the area where the procedure is performed,
will provide better pain control.
Each patient enrolled on this study will have three different anesthetic combinations for
three different procedures, in order to determine which combination worked best for each
child.
Clinical Details
Official title: Fentanyl-Propofol-EMLA or L.M.X4™ Technique for Bone Marrow Aspiration in Pediatric Patients - A Phase III Study
Study design: Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Crossover Assignment, Safety/Efficacy Study
Primary outcome: To study pain control during and after procedures such as bone marrow aspiration and lumbar puncture with intrathecal chemotherapy by using a combination of EMLA or L.M.X4™ cream, the analgesic drug fentanyl, and the anesthetic drug propofolTo study and determine which combinations of fentanyl, propofol, and EMLA or L.M.X4™ achieve the best pain control for these procedures
Eligibility
Minimum age: 2 Years.
Maximum age: 17 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Age: 2-17 years old.
- Subjects undergoing bone marrow aspiration (unilateral) with lumbar puncture and
intrathecal chemotherapy.
- Subjects with acute lymphoblastic leukemia or lymphoblastic lymphoma in remission or
are having anticipated remission procedures occurring at the end of remission
induction.
Locations and Contacts
St. Jude Children's Research Hospital, Memphis, Tennessee 38105, United States
Additional Information
St. Jude Children's Research Hospital
Starting date: March 2002
Ending date: August 2008
Last updated: June 2, 2008
|